HAEMONETICS CORP - Common stock, $0.01 par value per share (HAE)

CUSIP: 405024100

Q3 2020 13F Holders as of 30 Sep 2020

Holder snapshot 7 signals
Share change
-2,638
Put/Call ratio
64%
SEC-reported price per share
$87.25
Indexed holders
261
Value change
-$6,823,951
Number of buys
123
Open additional details 1 more signal available
Number of sells
158
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
45,420,621

Security key

405024100

Report period

Q3 2020

Indexed institutions

261

Top holders

10

Ownership snapshot

Top reported holders of HAE - HAEMONETICS CORP - Common stock, $0.01 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
VANGUARD GROUP INC
Disclosed value leader
VANGUARD GROUP INC
Comparable rows
0/15
Latest evidence
30 Jun 2020
13F Highest disclosed value: $474,758,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

VANGUARD GROUP INC has the largest disclosed position value at $474.76M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens VANGUARD GROUP INC's linked filing trail.
Disclosed position value Top 5
VANGUARD GROUP INC $474.76M
BlackRock Finance, Inc. $456.36M
Capital Research Global Investors $357.17M
Neuberger Berman Group LLC $277.69M
Jackson Square Partners, LLC $205.82M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$474,758,000
5,301,013 shares
— 30 Jun 2020
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$456,365,000
5,095,602 shares
— 30 Jun 2020
Capital Research Global Investors
13F
Company
13F
—
denominator unverified
$357,166,000
3,988,003 shares
— 30 Jun 2020
Neuberger Berman Group LLC
13F
Company
13F
—
denominator unverified
$277,693,000
3,101,345 shares
— 30 Jun 2020
Jackson Square Partners, LLC
13F
Company
13F
—
denominator unverified
$205,825,000
2,298,190 shares
— 30 Jun 2020
RENAISSANCE TECHNOLOGIES LLC
13F
Company
13F
—
denominator unverified
$195,938,000
2,187,785 shares
— 30 Jun 2020
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2020

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
261
Shares
49,419,749
Indexed holders
261
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q3 2020 vs Q2 2020 Across Filers

Q2 2020 indexed holders
276
Q3 2020 indexed holders
261
Indexed holder difference
-15
Investor Q2 2020 Shares Q3 2020 Shares Share Diff Share Chg % Q2 2020 value Q3 2020 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .